$HSTM

REBROVICK LINDA sold $50K of HSTM

REBROVICK LINDA sold 2,000 shares of HEALTHSTREAM INC (HSTM) at $25.00 on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · REBROVICK LINDA
Published Jun 1, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 9:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HSTM
Neutral
medium confidence
Mentioned
$HSTM
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HSTMNeutralLow
01

Why it matters

The newest fact is the specific open-market sale of 2,000 shares at $25.00, with holdings after the trade and confirmation of a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 designation and modest size reduce expected fundamental impact.

03

What to watch

The article does not provide context on total insider holdings changes over time, nor whether other insiders sold or bought around the same period.

Relevance 2/10Novelty 3/10Timing: filed June 1, transaction dated May 28

Background

This is an SEC Form 4 insider transaction disclosure for HealthStream, reported via EDGAR.

Company-level read

Ticker impact

$HSTMNeutralMedium confidence
Context

HealthStream director Linda Rebrovick sold 2,000 shares in an open-market transaction at $25.00 on May 28 under a 10b5-1 plan.

Expected impact

Likely minimal immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

Form 4 shows a modest dollar value ($50k) and explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No clear sector read-through from a single, small 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations, so traders may ignore it.

Key entities

  • HEALTHSTREAM INC

    US-listed company whose director insider sale is disclosed on Form 4.

  • REBROVICK LINDA

    Director who sold 2,000 shares under a 10b5-1 plan.

Related articles